What is Javara?
Javara operates as a leading Integrated Research Organization (IRO), dedicated to facilitating clinical trial access within large healthcare organizations at the point of care. By integrating research staff and infrastructure, Javara leverages its access to diverse patient populations through trusted physicians to ensure high enrollment and retention rates, thereby delivering quality data. The company's centralized resources and standardized operations are designed to enhance efficiencies for accelerated study start-up and improved outcomes, streamlining the product approval pathway. Javara is recognized as a pioneer of Clinical Research as a Care Option (CRAACO), aiming to transform healthcare by connecting appropriate patients with suitable trials at the optimal time.
How much funding has Javara raised?
Javara has raised a total of $4.8M across 2 funding rounds:
Debt
$150K
Unspecified
$4.6M
Debt (2020): $150K with participation from PPP
Unspecified (2020): $4.6M, investors not publicly disclosed
Key Investors in Javara
PPP
Public-Private Partnership
What's next for Javara?
With its recent major enterprise-level funding, Javara is strategically positioned to further scale its operations and expand its reach within the healthcare ecosystem. This capital injection is expected to accelerate the company's mission of integrating clinical research as a standard care option, enhancing its infrastructure for clinical trial delivery, and broadening its partnerships with healthcare organizations. The focus will likely remain on optimizing study start-up times, improving data quality through robust patient enrollment and retention, and ultimately contributing to a more efficient product approval process for new therapies. Javara's continued growth signifies a strong market demand for its innovative approach to clinical research delivery.
See full Javara company page
